Akero Therapeutics, Inc. (AKRO)
NASDAQ: AKRO · Real-Time Price · USD
38.64
-1.84 (-4.55%)
At close: Apr 1, 2025, 4:00 PM
38.00
-0.64 (-1.66%)
After-hours: Apr 1, 2025, 7:37 PM EDT

Akero Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2017
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2017
Net Income
-252.06-151.76-112.03-100.78-79.21
Upgrade
Depreciation & Amortization
0.020.030.040.040.02
Upgrade
Other Amortization
0.610.790.2--
Upgrade
Asset Writedown & Restructuring Costs
1----
Upgrade
Loss (Gain) From Sale of Investments
-13.12-9.55-0.011.070.08
Upgrade
Stock-Based Compensation
29.721.523.2410.056.02
Upgrade
Other Operating Activities
0.750.310.50.210.2
Upgrade
Change in Accounts Payable
2.01-0.650.973.272.48
Upgrade
Change in Other Net Operating Assets
0.99-6.03-5.436.45-0.4
Upgrade
Operating Cash Flow
-230.11-145.37-92.52-79.68-70.8
Upgrade
Capital Expenditures
-1----0.15
Upgrade
Investment in Securities
-108.71-223.62-63.8342.28-9.61
Upgrade
Investing Cash Flow
-109.71-223.62-63.8342.28-9.76
Upgrade
Long-Term Debt Issued
101510--
Upgrade
Net Debt Issued (Repaid)
101510--
Upgrade
Issuance of Common Stock
436.69339.09246.51.12203.96
Upgrade
Other Financing Activities
-0.84-0.78-0.86-0.52-0.85
Upgrade
Financing Cash Flow
445.85353.32255.630.6203.11
Upgrade
Net Cash Flow
106.03-15.6799.29-36.8122.54
Upgrade
Free Cash Flow
-231.11-145.37-92.52-79.68-70.95
Upgrade
Free Cash Flow Per Share
-3.44-2.77-2.37-2.29-2.25
Upgrade
Cash Interest Paid
3.982.480.44--
Upgrade
Levered Free Cash Flow
-148.48-94.05-53.51-43.22-41.98
Upgrade
Unlevered Free Cash Flow
-146.17-92.56-53.25-43.22-41.98
Upgrade
Change in Net Working Capital
-3.516.384.57-9.74-2.22
Upgrade
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q